Seqster and Boston University have expanded their partnership, pursuant to which, the latter will use Seqster’s Research Portal (SRP) solution that enables study participants to instantly collect and share medical records and device data with researchers.
As part of the collaboration, Boston University will use Seqster’s SRP for its Alzheimer’s Disease Center (ADC) Cohort Digital Technology Study to control the long-standing data collection hurdle for Alzheimer’s clinical trials.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The partnership will see acquisition of various data sources in an intuitive longitudinal view, while accessing medical records directly through the portal.
It will also enable Boston University to expedite Alzheimer’s disease research by advancing patients’ access to their clinical data.
The combined study will check for the feasibility of using wearable technology to identify differences between cognitively normal, mild cognitively impaired, and Alzheimer’s disease participants.
The devices, in combination with smartphone applications, will be used to gather details of lifestyle of participants, contributing to the understanding of indicators of cognitive impairment and Alzheimer’s disease.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBoston University Schools of Medicine and Public Health Anatomy & Neurobiology, Neurology and Epidemiology professor Rhoda Au said: “We are using the Seqster platform for our digital brain health study through the Alzheimer’s Disease Center.
“Seqster’s SRP allows the aggregation of data collected from multiple medical records (EHR) plus devices used in the study (e.g., Apple, Fitbit, Withings, Garmin) as well as providing our research team longitudinal health data without requiring participants to fill out long health history questionnaires.”
More than 5.8 million people are living with Alzheimer’s disease in the US.
Seqster CEO and co-founder Ardy Arianpour said: “Our proprietary SRP platform significantly decreases the time, friction and cost of importing Real- World Data (RWD) and Real-World Evidence (RWE) with a direct chain of custody to any clinical study.”
